Sign inJoin waitlistJoin the waitlist

William Blum

Physician · Emory University School of Medicine

Credentials: · · · ·

History

Emory University School of Medicine
Present

Hematology and Medical Oncology
Washington University School of Medicine
2000–2003
Internal Medicine
1997–2000
Medical College of Georgia
1993–1997

Research

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
Cancer Discovery · 2016 · 940 citations
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
Blood · 2009 · 642 citations
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
Journal of Clinical Investigation · 2008 · 530 citations

Adam Olszewski
124 papers
Allen Seiden
124 papers
Brandi Wynne
124 papers
EB
Emerald Rose Branch
124 papers · 122 as a resident
Harpreet Bawa
124 papers · 114 as a resident
IN
Ichiro Nakano
124 papers
KD
Karl Desch
124 papers
Robert Nickerson
124 papers
Sanjay Rajagopalan
124 papers
Tyler Bold
124 papers · 95 as a resident
HM
Hayk Manuk-Hakobyan
122 papers
Frank Seifert
115 papers

Grants

Maintenance Therapy with Decitabine for Acute Myeloid Leukemia in First Remission
National Cancer Institute · R21
Contact PI · $660K · Ohio State University
2009–2013
Experimental Therapeutics in Acute Leukemias
National Cancer Institute · K23
Contact PI · $648.6K · Ohio State University
2006–2011

Clinical trials

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Principal investigator · Recruiting · Phase 1
Meryx, Inc.
2022–2026
Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia
Principal investigator · Terminated · Phase 2
Emory University
2016–2018
Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia
Principal investigator · Terminated · Phase 2
Emory University
2016–2018
Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2010–2014